Natural Compounds Targeting SARS-CoV-2 Protease and RBD
2026-08-31
The reference study used virtual screening, molecular docking, and molecular dynamics to evaluate vitamin-derived compounds against both the SARS-CoV-2 main protease and the spike receptor-binding domain. Its central contribution is a dual-target prioritization strategy that identifies overlapping and target-specific candidates for follow-up antiviral therapeutics research, while remaining strictly computational in scope.
SM-164: Reliable IAP-Targeted Apoptosis Assays
2026-08-30
Learn how SM-164 (SKU A8815) can improve the interpretation and reproducibility of viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers mechanism, solubility, assay controls, protocol handling, data interpretation, and practical supplier selection.
Flavopiridol Workflows for CDK and Stress Assays
2026-08-29
Flavopiridol (L868275) provides a practical way to connect CDK-driven cell-cycle phenotypes with apoptosis and stress-response readouts. This workflow-focused guide covers formulation, assay design, intestinal stem-cell translation, and troubleshooting for reproducible cancer research.
LY2603618: Selective Chk1 Inhibitor Guide
2026-08-29
LY2603618 is an ATP-competitive Chk1 inhibitor for studying replication stress, DNA damage response, and cell cycle control. Product data describe G2/M arrest, increased H2AX phosphorylation, abnormal prometaphase accumulation, and enhanced activity with gemcitabine in a Calu-6 xenograft model.
Phenothiazines Boost Macrophage Antibacterial Activity
2026-08-28
A 2025 Frontiers in Immunology study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage defenses through reactive oxygen species, lysosomal activity, and autophagy. Perphenazine reduced organ lesions and inflammation in a Salmonella Typhimurium infection model, but the findings support a research direction rather than a validated clinical antibacterial application.
FPH1 (BRD-6125) Hepatocyte Assay Guide
2026-08-28
Learn how FPH1 (BRD-6125), supplied as SKU B3701, can support functional hepatocyte proliferation, iPSC-derived hepatocyte workflows, and more interpretable viability assays. This scenario-based guide covers dosing, DMSO handling, readout selection, and practical vendor evaluation.
Tyrothricin Workflows for Membrane Research
2026-08-27
Build reproducible antimicrobial assays around Tyrothricin, a peptide antibiotic mixture suited to membrane-disruption, bacterial, fungal, and exploratory viral workflows. The article combines practical dose-response design with pathway-aware controls inspired by recent trigeminal ganglion research, while clearly separating established evidence from assay-development recommendations.
3-Deazaadenosine Hydrochloride in SAHH Workflows
2026-08-27
Build reproducible methylation-perturbation assays with 3-Deazaadenosine hydrochloride, from dose-finding in hepatic stellate cells to orthogonal readouts of proliferation and activation. The workflow distinguishes upstream SAHH inhibition from direct m6A-reader targeting, helping researchers interpret fibrosis and inflammation results with greater mechanistic precision.
Vorinostat for HDAC-Driven Cancer Assays
2026-08-26
Vorinostat (SAHA) provides a practical benchmark for connecting HDAC inhibition with chromatin remodeling, cell-cycle arrest, and intrinsic apoptosis. This workflow shows how to separate cytostatic effects from cell death and extend the readout across lymphoma, neuroblastoma, and broader cancer biology research.
TRPV1 and TRPA1: Bifurcated ROS Sensing
2026-08-26
The reference study shows that TRPV1 and TRPA1 do not interpret reactive oxygen species uniformly: singlet oxygen potentiates TRPV1 but produces transient activation followed by inhibition of TRPA1, whereas hydrogen peroxide activates both channels with different sensitivities. By combining electrophysiology, calcium imaging, agonist discrimination, and residue-level analysis, the work defines a framework for understanding ROS-specific ion-channel regulation.
ATRX-Deficient Glioma Sensitivity to PDGFR Inhibitors
2026-08-25
Pladevall-Morera and colleagues used an FDA-approved drug screen to show that ATRX-deficient high-grade glioma cells are particularly vulnerable to several receptor tyrosine kinase and PDGFR inhibitors. The study also found enhanced toxicity when selected RTK inhibitors were combined with temozolomide, supporting ATRX status as a useful variable for interpreting targeted-therapy studies.
3D DNA Frameworks Improve Enzymatic DNA Synthesis
2026-08-25
The reference study introduces tetrahedral DNA nanostructures as an ordered interface for presenting primers during enzymatic oligonucleotide synthesis. By improving primer accessibility and reducing deletion errors, the framework produced a reported 96.82% stepwise yield in a 60-nucleotide DNA information-storage sequence.
Erastin at the Ferroptosis Execution Frontier
2026-08-24
Erastin is more than a standard ferroptosis inducer: it is a mechanistic probe for connecting redox collapse, lipid-peroxide-driven membrane injury, and tumor immune biology. This thought-leadership guide translates recent findings on TMEM16F-mediated lipid scrambling into practical strategies for cancer biology research, oxidative stress assays, and translational ferroptosis studies.
T-5224: C-Fos/AP-1 Inhibitor for Research
2026-08-23
T-5224 is a selective C-Fos/AP-1 inhibitor that blocks c-Fos/c-Jun DNA binding and suppresses inflammatory and osteoclastogenic signaling. Product information reports activity against MMPs, IL-6, IL-1β, TNF-α, and NFAT, including efficacy benchmarks in a collagen-induced arthritis model.
YAP–TEAD and Super-Enhancers in Ectoderm Commitment
2026-08-22
A 2026 Nucleic Acids Research study maps how super-enhancers and three-dimensional chromatin contacts regulate early surface ectoderm commitment from pluripotent stem cells. Its central contribution is to connect enhancer architecture with causal CRISPR-dCas9 perturbation and YAP–TEAD activity, providing a mechanistic framework for epithelial differentiation and regenerative research.
464 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page